Phase 4: Antioxidant and barrier protection The protocol includes antioxidants (rutin, camellia sinensis extract) and hydration agents (hyaluronic acid), to help neutralise oxidative stress involved in melanogenesis and support epidermal barrier function to reduce inflammation- driven pigmentation
Reported subcutaneous PT-141 timeline Time after subQ dose 0-30 minutes What was reported Possible flushing
Retatrutide 15mg Summary Description: Retatrutide is a next-generation investigational medication initially developed for the treatment of obesity and type 2 diabetes, with emerging evidence highlighting its potential multi-system benefits
While that's substantially higher than the 600mg starting dose we generally favor for people new to NAC, it reflects the GlyNAC protocols studied in healthy-aging research.34 57 58 Some readers may prefer to start with a smaller serving for tolerability, but the clinical research on GlyNAC has generally evaluated gram-level doses of both ingredients, so it's unclear whether substantially lower amounts would provide the same benefits
NAI have not had any input (financial, intellectual, or otherwise) into this review
